Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fosteson, Christina
NCT04804033: A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention	Terminated	2/3	538	US	BHV-3500 (zavegepant), Placebo	Pfizer	Migraine	03/24	03/24
ASLAN004-003, NCT05158023: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis	Completed	2	302	Europe, Canada, US, RoW	Placebo Comparator, ASLAN004	ASLAN Pharmaceuticals	Atopic Dermatitis	06/23	09/23
Raoof, Tooraj
No trials found